These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 22531757)
1. Using tuberculin skin test as an entry point to screen for latent and active tuberculosis in Thai people living with HIV. Phanuphak N; Varma JK; Kittikraisak W; Teeratakulpisarn N; Phasitlimakul S; Suwanmala P; Pankam T; Burapat T; Tasaneeyapan T; McCarthy KD; Cain KP; Phanuphak P J Acquir Immune Defic Syndr; 2012 Aug; 60(4):384-92. PubMed ID: 22531757 [TBL] [Abstract][Full Text] [Related]
2. Relevance and acceptability of using the Quantiferon gold test (QGIT) to screen CD4 blood draws for latent TB infection among PLHIV in South Africa: formative qualitative research findings from the TEKO trial. Kerrigan D; Tudor C; Motlhaoleng K; Lebina L; Qomfu C; Variava E; Chon S; Martinson N; Golub JE BMC Health Serv Res; 2018 Apr; 18(1):288. PubMed ID: 29661197 [TBL] [Abstract][Full Text] [Related]
3. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF. Orlando S; Triulzi I; Ciccacci F; Palla I; Palombi L; Marazzi MC; Giuliano M; Floridia M; Mancinelli S; Mutemba E; Turchetti G PLoS One; 2018; 13(7):e0200523. PubMed ID: 30024890 [TBL] [Abstract][Full Text] [Related]
4. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube. Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of ESAT6-CFP10 Skin Test for Lu P; Wu K; Zhou H; Yu H; Yuan J; Dong L; Liu Q; Ding X; Lu W; Yang H; Zhu L; Martinez L J Clin Microbiol; 2023 Apr; 61(4):e0181622. PubMed ID: 36946732 [TBL] [Abstract][Full Text] [Related]
6. Programmatic Evaluation of an Algorithm for Intensified Tuberculosis Case Finding and Isoniazid Preventive Therapy for People Living With HIV in Thailand and Vietnam. Cowger TL; Thai LH; Duong BD; Danyuttapolchai J; Kittimunkong S; Nhung NV; Nhan DT; Monkongdee P; Thoa CK; Khanh VT; Nateniyom S; Yen NTB; Ngoc DV; Thinh T; Whitehead S; Pevzner ES J Acquir Immune Defic Syndr; 2017 Dec; 76(5):512-521. PubMed ID: 29023251 [TBL] [Abstract][Full Text] [Related]
7. Screening and testing for tuberculosis among the HIV-infected: outcomes from a large HIV programme in western Kenya. Owiti P; Onyango D; Momanyi R; Harries AD BMC Public Health; 2019 Jan; 19(1):29. PubMed ID: 30621655 [TBL] [Abstract][Full Text] [Related]
8. An observational study identifying highly tuberculosis-exposed, HIV-1-positive but persistently TB, tuberculin and IGRA negative persons with M. tuberculosis specific antibodies in Cape Town, South Africa. Kroon EE; Kinnear CJ; Orlova M; Fischinger S; Shin S; Boolay S; Walzl G; Jacobs A; Wilkinson RJ; Alter G; Schurr E; Hoal EG; Möller M EBioMedicine; 2020 Nov; 61():103053. PubMed ID: 33038764 [TBL] [Abstract][Full Text] [Related]
9. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Diel R; Loddenkemper R; Meywald-Walter K; Niemann S; Nienhaus A Am J Respir Crit Care Med; 2008 May; 177(10):1164-70. PubMed ID: 18276940 [TBL] [Abstract][Full Text] [Related]
10. TB screening among people living with HIV/AIDS in resource-limited settings. Date A; Modi S J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3():S270-3. PubMed ID: 25768866 [TBL] [Abstract][Full Text] [Related]
11. Relating Tuberculosis (TB) Contact Characteristics to QuantiFERON-TB-Gold and Tuberculin Skin Test Results in the Toronto Pediatric TB Clinic. Rose W; Read SE; Bitnun A; Rea E; Stephens D; Pongsamart W; Kitai I J Pediatric Infect Dis Soc; 2015 Jun; 4(2):96-103. PubMed ID: 26407408 [TBL] [Abstract][Full Text] [Related]
12. Diagnosing active and latent tuberculosis among Iranian HIV-infected patients. Baghaei P; Esmaeili S; Farshidpour M; Javanmard P; Marjani M; Moniri A; Nemati K; Tabarsi P Clin Respir J; 2018 Jan; 12(1):62-67. PubMed ID: 27059900 [TBL] [Abstract][Full Text] [Related]
13. Implementing an isoniazid preventive therapy program for people living with HIV in Thailand. Danyuttapolchai J; Kittimunkong S; Nateniyom S; Painujit S; Klinbuayaem V; Maipanich N; Maokamnerd Y; Pevzner E; Whitehead S; Kanphukiew A; Monkongdee P; Martin M PLoS One; 2017; 12(9):e0184986. PubMed ID: 28949995 [TBL] [Abstract][Full Text] [Related]
14. Tuberculosis screening in Portuguese healthcare workers using the tuberculin skin test and the interferon-gamma release assay. Torres Costa J; Sá R; Cardoso MJ; Silva R; Ferreira J; Ribeiro C; Miranda M; Plácido JL; Nienhaus A Eur Respir J; 2009 Dec; 34(6):1423-8. PubMed ID: 19948911 [TBL] [Abstract][Full Text] [Related]
15. Access and adherence to isoniazid preventive therapy and occurrence of active TB in a cohort of people living with HIV: a retrospective cohort study in Sao Paulo, Brazil. Picone CM; Freitas AC; Gutierrez EB; Avelino-Silva VI Rev Inst Med Trop Sao Paulo; 2020; 62():e8. PubMed ID: 32049259 [TBL] [Abstract][Full Text] [Related]
16. Tuberculin skin test and QuantiFERON-TB Gold In-tube Test for latent tuberculosis in Thai HIV-infected adults. Khawcharoenporn T; Apisarnthanarak A; Phetsuksiri B; Rudeeaneksin J; Srisungngam S; Mundy LM Respirology; 2015 Feb; 20(2):340-7. PubMed ID: 25428131 [TBL] [Abstract][Full Text] [Related]
17. [Comparison of Tuberculin Skin Test (TST) and T-SPOT.TB Tests for Diagnosis of Latent Tuberculosis Infection (LTBI) in HIV-infected Patients]. Binay UD; Fincancı M; Fersan E; Karakeçili F Mikrobiyol Bul; 2019 Oct; 53(4):388-400. PubMed ID: 31709936 [TBL] [Abstract][Full Text] [Related]
18. [Update of the guidelines of the Israeli Association of Rheumatology for the prevention of tuberculosis in patients treated with TNF-alpha blockers]. Balbir-Gurman A; Lidgi M; Elkayam O Harefuah; 2014 Jun; 153(6):359-61, 366. PubMed ID: 25095612 [TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial. Ruhwald M; Aggerbeck H; Gallardo RV; Hoff ST; Villate JI; Borregaard B; Martinez JA; Kromann I; Penas A; Anibarro LL; de Souza-Galvão ML; Sánchez F; Rodrigo-Pendás JÁ; Noguera-Julian A; Martínez-Lacasa X; Tuñez MV; Fernández VL; Millet JP; Moreno A; Cobos N; Miró JM; Roldan L; Orcau A; Andersen P; Caylá JA; Lancet Respir Med; 2017 Apr; 5(4):259-268. PubMed ID: 28159608 [TBL] [Abstract][Full Text] [Related]
20. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population. Ponce de Leon D; Acevedo-Vasquez E; Alvizuri S; Gutierrez C; Cucho M; Alfaro J; Perich R; Sanchez-Torres A; Pastor C; Sanchez-Schwartz C; Medina M; Gamboa R; Ugarte M J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]